Phreesia ran a survey of 137 rare disease patients to guide online engagement.
A partner needed to understand online behaviour of hard-to-reach rare disease patients. Phreesia ran a quantitative PatientInsights survey of 137 patients with a rare disease in their chart history and reached the sample within weeks. Findings include 66% active on Facebook and 63% more trusting of data-backed information.
Phreesia Life Sciences is the pharma services arm of the patient intake company Phreesia, used by brands for point-of-care messaging and patient research surveys
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Phreesia Life Sciences on its own site — read the original case study on engage.phreesia.com ↗
Note: Survey-based research product; PDF text read locally. AI is not named.
Related use cases
- 01How Bioventus evolved their commercial strategy with real world data and intelligence
- 02Clarivate and CLEO diagnostics are making early detection of ovarian cancer a reality
- 03Making informed investment decisions (Attracting breakthrough innovations from academic research) - SPRIND case study
- 04Gedeon Richter — Case study | Clarivate Regulatory Intelligence Tracking Application
- 05Integrating patient centricity into the Menarini mature brand strategy for commercial excellence
- 06Artificial Intelligence in Pharmacovigilance: Using AI to help GSK detect ICSRs in scientific literature